Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Next-Generation Immunohistochemistry: A Window Onto the Molecular Alterations in Tumors

Date: Thursday, Sep 24, 2020

Description: At the conclusion of this program, participants will be able to:

  • Identify the principal classes of molecular alterations that occur inhuman malignancies 
  • Explain several different types of changes, on the protein level, which can result from gene mutations occurring in tumors 
  • Describe examples of tumors manifesting unique chromosomal translocations and recognize how in situ hybridization and immunohistochemistry (IHC) techniques can be employed in their detection 
  • Summarize examples of tumors that are characterized by deletions and/or mutations of selected genes, resulting in loss of protein expression, and help in the identification these tumors by IHC

ASCLS P.A.C.E.® credits are available to laboratory professionals through March 23, 2021.

Author: 

Gown, Allen M., MD
Founder, Medical Director, Chief Pathologist
PhenoPath
Seattle, Washington

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.